🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT07022756
Starting soon Not applicable

Personalized Outreach for Equitable Treatment in Rheumatology

NCT07022756 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2025-07-02
Last updated
2025-07-04

Condition(s) studied

Rheumatic DiseasesInflammatory ArthritisRheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)Connective Tissue Disease

Investigational drug(s) / intervention(s)

HonorariaOutreach

Honoraria: A $20 honorarium for each appointment attended with completed bloodwork if requested.

Outreach: A personalized outreach service specific for rheumatic disease.

Study summary

The primary goal of this study is to determine whether providing patient honoraria and/or outreach services can improve the attendance rate of appointments at an inner city rheumatology clinic in Vancouver, British Columbia.

The main question it aims to answer are:

* Does providing a financial honorarium ($20 for each follow-up appointment with completed bloodwork) improve attendance rate at an inner city rheumatology clinic?
* Does providing a personalized outreach service for rheumatic diseases improve attendance rate at an inner city rheumatology clinic?

The researchers will compare providing patient honoraria to providing both honoraria and outreach services, and compare each of these to the regular appointment schedule without honoraria or outreach.

Participants will:

* Undergo randomization to receive honoraria or honoraria and outreach services together
* Complete surveys about their health and understanding of their rheumatic disease at baseline, 3-month, and 6-month intervals
* Visit the clinic every month for check-ups and monitoring bloodwork if they are started on immunosuppressants for their condition

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Have a diagnosis of inflammatory arthritis secondary to an autoimmune rheumatic disease * Be attached to one of the Vancouver Coastal Health Community Health Centres for primary care * Be willing to attend in-person appointments at Pender Community Health Centre * Be at least 18 years of age and capable of consenting to participation * Be able to receive medical care in English. Exclusion Criteria: * Have cognitive impairment or an untreated psychiatric condition that would severely impair ability to engage with outreach or treatment * Have no reasonably reliable method of contact (phone, email, social media, etc.)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Pender Community Health Centre Vancouver British Columbia

More University of British Columbia trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07022756 on ClinicalTrials.gov ↗ ← All trials in Canada